OBJECTIVE: The objective of the study was to measure associations between bowel symptoms and prolapse. STUDY DESIGN: Baseline data were analyzed from 322 women in the Colpopexy And Urinary Reduction Efforts trial of sacrocolpopexy with or without Burch colposuspension. Women completed the Colorectal-Anal Distress Inventory and Colorectal-Anal Impact Questionnaire and underwent Pelvic Organ Prolapse Quantification. Associations between symptoms and questionnaire scores and Pelvic Organ Prolapse Quantification measures were assessed. RESULTS: Mean age was 61 +/- 10 years. Pelvic Organ Prolapse Quantification stages were II (14%), III (67%), and IV (19%). Colorectal-Anal Distress Inventory symptoms did not increase with prolapse stage. Colorectal-Anal Distress Inventory obstructive subscale scores were higher in stage II women (median 29 [interquartile range 8,92] versus 17 [0,33] and 25 [0,38] for stages III and IV, respectively; adjusted P = .01). The few statistically significant correlations between symptoms and vaginal descent were negative and weak (less than 0.2). CONCLUSION: Bowel symptoms and questionnaire scores do not increase with prolapse stage in women presenting for sacrocolpopexy.
OBJECTIVE: The objective of the study was to measure associations between bowel symptoms and prolapse. STUDY DESIGN: Baseline data were analyzed from 322 women in the Colpopexy And Urinary Reduction Efforts trial of sacrocolpopexy with or without Burch colposuspension. Women completed the Colorectal-Anal Distress Inventory and Colorectal-Anal Impact Questionnaire and underwent Pelvic Organ Prolapse Quantification. Associations between symptoms and questionnaire scores and Pelvic Organ Prolapse Quantification measures were assessed. RESULTS: Mean age was 61 +/- 10 years. Pelvic Organ Prolapse Quantification stages were II (14%), III (67%), and IV (19%). Colorectal-Anal Distress Inventory symptoms did not increase with prolapse stage. Colorectal-Anal Distress Inventory obstructive subscale scores were higher in stage II women (median 29 [interquartile range 8,92] versus 17 [0,33] and 25 [0,38] for stages III and IV, respectively; adjusted P = .01). The few statistically significant correlations between symptoms and vaginal descent were negative and weak (less than 0.2). CONCLUSION:Bowel symptoms and questionnaire scores do not increase with prolapse stage in women presenting for sacrocolpopexy.
Authors: Andrea K Crane; Elizabeth J Geller; Erinn M Myers; Jacquia L Fenderson; Ellen Wells; Mary Jannelli; AnnaMarie Connolly; Catherine A Matthews Journal: Int Urogynecol J Date: 2014-07-26 Impact factor: 2.894
Authors: Cara L Grimes; Emily S Lukacz; Marie G Gantz; Lauren Klein Warren; Linda Brubaker; Halina M Zyczynski; Holly E Richter; J Eric Jelovsek; Geoffrey Cundiff; Paul Fine; Anthony G Visco; Min Zhang; Susan Meikle Journal: Female Pelvic Med Reconstr Surg Date: 2014 Sep-Oct Impact factor: 2.091
Authors: Cara L Grimes; Rosanna H Overholser; Ronghui Xu; Jasmine Tan-Kim; Charles W Nager; Keisha Y Dyer; Shawn A Menefee; Gouri B Diwadkar; Emily S Lukacz Journal: Int Urogynecol J Date: 2016-05-26 Impact factor: 2.894
Authors: Marie-Andrée Harvey; Hui Ju Chih; Roxana Geoffrion; Baharak Amir; Alka Bhide; Pawel Miotla; Peter F W M Rosier; Ifeoma Offiah; Manidip Pal; Alexandriah Nicole Alas Journal: Int Urogynecol J Date: 2021-08-02 Impact factor: 2.894